Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Neuroblastoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Ganglioneuroblastoma 3Burkitt Lymphoma 3Urinary Bladder Neoplasms 2Rhabdomyosarcoma, Embryonal 2Rhabdomyosarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Biphenotypic, Acute 2Breast Neoplasms 2Teratoma 1Squamous Cell Carcinoma of Head and Neck 1Rhabdomyosarcoma, Alveolar 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lung Neoplasms 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Acute 1Leukemia 1

Interventions

Radiotherapy 10Vincristine 9Dactinomycin 8Cyclophosphamide 8Radiation 6Ifosfamide 6Doxorubicin 5Irinotecan 4Filgrastim 4Etoposide 4Vinorelbine 3sargramostim 2Specimen Handling 2Magnetic Resonance Spectroscopy 2Granulocyte Colony-Stimulating Factor 2Biopsy 2trofosfamide 1trioctyl phosphine oxide 1temsirolimus 1pegfilgrastim 1etoposide phosphate 1X-Rays 1Topotecan 1Surgical Procedures, Operative 1Spinal Puncture 1Sirolimus 1Sentinel Lymph Node Biopsy 1Phantoms, Imaging 1Idarubicin 1Granulocyte-Macrophage Colony-Stimulating Factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Rhabdomyosarcoma × Biopsy × Clear all
NCT04994132 2026-05-05

A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma

Children's Oncology Group

Phase 3 Active not recruiting
118 enrolled
Sarcoma

Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal

NCT07466316 2026-03-12

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

Children's Oncology Group

Phase 3 Not yet recruiting
342 enrolled
Sarcoma

Rhabdomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡